Olphas Product Portfolio: Active Pharmaceutical Ingredients (APIs) & Finished Dosage Forms (FDFs)

Product Description

Olpha is ready to support your company's strategic goals with our state-of-the-art production plant and expertise in pharmaceutical contract manufacturing.
Our Manufacturing Capabilities:
Formulation Development and Optimization: Tablets, capsules, sachets Scalable Production: From pilot series to validation series Compatibility Studies: Drug and excipient compatibility 
Technology Transfer: From development to production 
Our Services:
Research: Quality control, research laboratories, FDF development, API development 
Manufacturing: Scale-up, contract manufacturing for FDFs (including powders in sachets, tablets, capsules), APIs and intermediates, batch release 
Packaging: Blisters, sachets, labeling Distribution: Logistics, pharmacy chains, wholesalers 

Olpha, JSC

  • Country/Region:
    Latvia
  • On CPHI since:
    2025
  • Certificates:
    4
  • Employees:
    500 - 999
Company types
CMO/CDMO
Pharmaceutical company
Primary activities
Generic APIs producer
Pharmaceutical Company (generic finished products)

Olpha, JSC

  • Country/Region:
    Latvia
  • On CPHI since:
    2025
  • Certificates:
    4
  • Employees:
    500 - 999
Company types
CMO/CDMO
Pharmaceutical company
Primary activities
Generic APIs producer
Pharmaceutical Company (generic finished products)

Olpha, JSC resources (1)

  • Video About Olpha

    Key Benefits of Partnering with Olpha:
    Access to high-quality pharmaceutical products backed by extensive research and development from EU. Collaboration with a company that values ethical business practices and regulatory compliance. Opportunities for co-marketing and joint business development initiatives. GMP certification: EU GMP: Compliant for APIs and FDFs 
    U.S. FDA GMP: Certified for selected APIs 
    Australian TDA: Certified for FDFs 
    Japanese PMDA GMP: Certified for selected APIs 
    Turkey GMP: Certified for FDFs